SIGFOX
6.1.2022 11:02:07 CET | Business Wire | Press release
Sigfox, a world’s leading IoT (Internet of Things) communication service provider and 0G network pioneer, today announces its partnership with HT Micron, a Brazilian expert in advanced semiconductor solutions, and Nowi, a semiconductor company that specializes in the development of energy harvesting power management technology, to explore and unlock the benefits of integrating energy harvesting into Sigfox devices.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220106005406/en/
This collaboration marks the first step for Sigfox towards a commercial development of energy harvesting modules to equip IoT devices and contribute to more sustainability in IoT. Key use cases are applications in Smart metering, industrial sensoring, asset tracking and air quality monitoring.
During the research phase, HT Micron has worked on creating the innovative semiconductor solution to be integrated with Nowi’s Energy Harvesting PMIC (Power Management Integrated Circuit) designed especially for low power IoT devices. Equipped on Sigfox devices and powered by the 0G technology, this solution will help reduce battery consumption and offer longer autonomy while reducing the total cost of ownership.
Nowi PMIC is designed to efficiently extract power from ambient energy sources like light and vibration to charge a variety of energy storage elements such as a rechargeable battery or a capacitor. It is best suited for most low power applications like distributed IoT sensors and TV remote controls for example.
“The low power consumption of Sigfox solutions is particularly well suited to being powered by ambient energy harvesting. As many Sigfox-based applications require intermittent communication intervals, this allows for trickle charging a storage element with energy harvesting in between transmissions ,” explains Chris Juliano, CCO at Nowi .
Sigfox and HT Micron have been working together for several years already and HT Micron was identified as a strategic partner for this project as they have the expertise to create innovative modules and they consider energy harvesting essential for IoT mass adoption with sustainability.
“We are glad to take this next step with Sigfox and explore energy harvesting solutions as a new way to create added value to our end customers and help them improve their environmental impact ,” says Edelweis Ritt, CIO at HT Micron .
“This collaboration with Nowi and HT Micron is another proof point towards our ambition to create IoT solutions that will help our clients preserve the environment by greatly reducing their energy consumption. We are looking forward to the development of this new kind of devices and to the positive impact they will generate ” says Benjamin Jooris, Client & Ecosystem Success Director at Sigfox.
The first step of this project is a development kit integrating Nowi’s PMIC solution with HT Micron’s Sigfox system-in-package, to be used for testing purposes by R&D and product development teams. First information will be presented at CES 2022 (5-7 January in Las Vegas) at Nowi’s booth (#51733) to gather customer and developers’ feedback. Customers can register to receive the development kit. Next, Sigfox, Nowi and HT Micron will create a mass production module that can be used by any type of device maker.
This announcement comes as part of strengthening Sigfox's strategy to help reduce the human impact on the environment with IoT, and it will be soon followed by other solutions based on energy harvesting as new projects are already in discussion.
****
About Sigfox
Sigfox is a world’s leading IoT (Internet of Things) communication service provider and 0G network pioneer. Sigfox offers a unique combination of ultra-low cost and ultra-low power solutions enabled by a single global network, owned and operated by 75 Sigfox Operators, enabling businesses to gain visibility and track their assets worldwide. With more than 19 million connected devices and 75 million messages sent a day, Sigfox helps its customers to extract data at the lowest cost of production and accelerate their digital transformation in key areas such as asset tracking and monitoring.
ISO 9001 certified and supported by a strong partner ecosystem, Sigfox was founded in 2010 and is headquartered in Labège, France, with offices in Boston, Dallas, Dubai, Madrid, Paris, Sao Paulo, Singapore, and Tokyo.
About Nowi
Nowi is a semiconductor company founded in 2016, based in Delft, the Netherlands, with regional offices in the US and in Shanghai.
Nowi has developed energy harvesting power management ICs that combine top harvesting performance with the world’s smallest assembly footprint and lowest BOM cost. Thereby it simplifies the design process and lowers the threshold for any company to develop ‘Plug & Forget’ products.
About HT Micron
HT Micron provides advanced semiconductor solutions. The portfolio includes memories for computers, cell phones and smart TVs, as well as System-in-Package connectivity solutions for the Internet of Things. HT Micron is a Brazilian company, having as the main shareholder the South Korean group HANA Micron, and is based in the city of São Leopoldo, RS, in South Brazil.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220106005406/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release
Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (
Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release
Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,
BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release
The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu
Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release
Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo
Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release
Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets. “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.” Throughout his career, Dan has held senior leadership roles i
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
